MARATTO

article · Health Science Reports

Impacts of the advancement in artificial intelligence on laboratory medicine in low‐ and middle‐income countries: Challenges and recommendations—A literature review

202456 citationsOpen accessUniversity of Nigeria

In plain language

This study acknowledges the significant influence of artificial intelligence on laboratory medicine within low- and middle-income countries. It identifies several key challenges, including inadequate data availability, deficiencies in digital infrastructure, and ethical considerations. For successful implementation of AI, the research highlights the necessity of substantial investments in digital infrastructure, the establishment of robust data-sharing networks, and the development of clear regulatory frameworks. The study concludes that collaborative efforts are essential among various stakeholders, such as international organisations, governments, and non-governmental entities, to overcome these obstacles. A comprehensive and coordinated approach is crucial to fully realise AI's transformative potential and advance healthcare in these regions.

Key takeaways

  • Artificial intelligence profoundly impacts laboratory medicine in low- and middle-income countries.
  • Challenges to AI implementation include inadequate data, poor digital infrastructure, and ethical issues.
  • Successful AI integration requires significant investment in digital infrastructure, data-sharing networks, and regulatory frameworks.
  • Collaborative efforts between international organisations, governments, and non-governmental entities are crucial.
  • A comprehensive and coordinated approach is essential to leverage AI for healthcare advancement in these countries.

Why it matters

Understanding the challenges and recommendations for AI in laboratory medicine in low- and middle-income countries is vital. It highlights the systemic changes needed to harness AI's potential, ensuring that technological advancements contribute effectively to improving healthcare diagnostics and services in resource-constrained settings.

Commercialisation angle

The abstract focuses on the foundational requirements for integrating AI into laboratory medicine in low- and middle-income countries, rather than specific AI applications. It suggests that investments in digital infrastructure, data-sharing platforms, and regulatory frameworks are necessary preconditions. This work could inform policy and investment strategies for organisations aiming to facilitate AI adoption in healthcare, but it does not indicate a direct commercialisation pathway for a specific product or service.

AI-generated from the published abstract. Always read the original work before citing.

Abstract

While acknowledging the profound impact of AI on laboratory medicine in LMICs, the study recognizes challenges such as inadequate data availability, digital infrastructure deficiencies, and ethical considerations. Successful implementation necessitates substantial investments in digital infrastructure, the establishment of data-sharing networks, and the formulation of regulatory frameworks. The study concludes that collaborative efforts among stakeholders, including international organizations, governments, and nongovernmental entities, are crucial for overcoming obstacles and responsibly integrating AI into laboratory medicine in LMICs. A comprehensive, coordinated approach is essential for realizing AI's transformative potential and advancing health care in LMICs.

Research topics

  • Artificial Intelligence in Healthcare and Education
  • COVID-19 diagnosis using AI
  • AI in cancer detection

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.1002/hsr2.1794

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.